
General information
Full name | INFRAFRONTIER, the European research infrastructure for the development, phenotyping, archiving and distribution of mammalian models |
Short name | INFRAFRONTIER |
Legal status | GmbH |
Operational status | fully operational |
| |
Coordinating institution | INFRAFRONTIER GmbH |
Scientific Director Administrative Director | Martin Hrabe de Angelis Daniel Lahne |
| |
RI member countries | AT, CA, CZ, DE, DK, ES, FI, FR, GR, IL, IT, NL, PT, SE, UK, EMBL |
Observer | - |
Website | www.infrafrontier.eu |
Contact | info [at] infrafrontier.eu |
National nodes
All INFRAFRONTIER nodes and their resources and services can be accessed through the central INFRAFRONTIER web portal.
Description of the organisation
Europe urgently needs to find solutions for the grand challenges in the area of health. Different forms of cancer, metabolic diseases such as diabetes and obesity, chronic lung diseases, cardiovascular diseases, rare diseases, and infectious diseases are global threats to socio-economic well-being.
Mammalian models have proven to be a key resource for biomedical research to understand human diseases and to develop treatments for them. Mouse studies have been key to the six of the last 10 Nobel Awards in Medicine and Physiology and to breakthrough discoveries in the functional basis of human health and disease and are used in pre-clinical screening and drug development. The INFRAFRONTIER Research Infrastructure provides access to centralised high-quality resources and data for the development, phenotyping, archiving and distribution of mammalian models. Access is provided for individual researchers (bottom-up access) and for national, European and international research programmes (top-down access).
Service offer
A list of services offered by INFRAFRONTIER can be downloaded here.